Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Test
Published . Updated .
Inventiva (NASDAQ:IVA) said it expects to report top-line results in the fourth quarter of 2026 from its fully enrolled Phase III NATiV3 trial of lanifibranor in patients with metabolic dysfunction-associated steatohepatitis, or MASH. Chief Executive Officer Andrew Obenshain sai
Directly affected
- NDAQ Nasdaq
Named in this report.
Indirectly affected
- GIEQ GOLDMAN SACHS ETF TR DATA ENHA
GA selected GIEQ as a RELATED security because its canonical security name directly matches this event's themes: data. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- RACK VANECK ETF TR VANECK DATA CENT
GA selected RACK as a RELATED security because its canonical security name directly matches this event's themes: data. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Inventiva (NASDAQ:IVA) said it expects to report top-line results in the fourth quarter of 2026 from its fully enrolled Phase III NATiV3 trial of lanifibranor in patients with metabolic dysfunction-associated steatohepatitis, or MASH. Chie…
Source: Nasdaq Markets
How far Goldman Sachs Etf Tr Data Enha (GIEQ) has moved since 5 Oct 2026
Since the first closing price after “Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Test,” Goldman Sachs Etf Tr Data Enha (GIEQ) is +0.22%. The S&P 500 fund (SPY) is -1.60% over the same days, a +1.82% difference versus the market.
Who gains and who loses around Goldman Sachs Etf Tr Data Enha (GIEQ)
Companies tied to this story
- GIEQ Goldman Sachs Etf Tr Data Enha
In “Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Test,” Goldman Sachs Etf Tr Data Enha (GIEQ) is linked, with no stored direction, medium confidence. Reason on file: GA selected GIEQ as a RELATED security because its canonical security name directly matches this event's themes: data. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- RACK Vaneck Etf Tr Vaneck Data Cent
Vaneck Etf Tr Vaneck Data Cent (RACK) is linked, with no stored direction, medium confidence in the 5 Oct 2026 story “Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Test.” Reason on file: GA selected RACK as a RELATED security because its canonical security name directly matches this event's themes: data. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Goldman Sachs Etf Tr Data Enha (GIEQ)
On 5 Oct 2026, “Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Test” is the story that connects Goldman Sachs Etf Tr Data Enha (GIEQ) to this story.
Goldman Sachs Etf Tr Data Enha (GIEQ) is on the page because GA selected GIEQ as a RELATED security because its canonical security name directly matches this event's themes: data. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Vaneck Etf Tr Vaneck Data Cent (RACK) is here too. Its reason reads: GA selected RACK as a RELATED security because its canonical security name directly matches this event's themes: data. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Goldman Sachs Etf Tr Data Enha (GIEQ), and the dates in the story
GIEQ traded between 41.01 and 42.36 across 6 sessions. The latest close on file is 41.10. RACK traded between 44.78 and 51.45 across 20 sessions. The latest close on file is 44.78.
How strong the case is around Goldman Sachs Etf Tr Data Enha (GIEQ)
21 out of 100
“Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Test” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.